Bristol Myers Squibb (BMY) Net Income (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Net Income of $2.16 billion in Q3 2026, down 1.8% from $2.2 billion a year earlier and down 34.8% from the prior quarter.
Bristol Myers Squibb (BMY) Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Net Income came in at $9.24 billion as of Sep 30, 2026, up 52.8% year-over-year; for FY2025, it came in at $7.06 billion.
- Across earlier years, Net Income came in at -$8.95 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
- Quarterly Net Income has ranged from -$11.91 billion in Q1 2024 to $3.32 billion in Q2 2026 over the past five years.
- On a year-over-year basis, Net Income rose in three of the last six quarters, with growth averaging 20.5%.
- Peak year-over-year performance for Net Income in the last five years was growth of 152.6% in Q2 2026, against a decline of 95.9% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.32 billion (Q2 2026), $2.68 billion (Q1 2026) and $1.09 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 2.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.16 Bn |
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 72.00 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
Bristol Myers Squibb Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();